Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: Preliminary results of the infant development, environment, and lifestyle study (IDEAL)

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 2, 2007, Pages 281-289

  Derauf, Chris ^a,i   LaGasse, Linda L ^b   Smith, Lynne M ^c   Grant, Penny ^d   Shah, Rizwan ^e   Arria, Amelia ^f   Huestis, Marilyn ^g   Haning, William ^a   Strauss, Arthur ^h   Della Grotta, Sheri ^b   Liu, Jing ^b   Lester, Barry M ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b E P BRADLEY HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e Blank Children's Hospital   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^h LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

ⁱ Department of Pediatrics ^*  (United States)

Author keywords

Maternal behavior; Methamphetamine; Parenting; Substance abuse

Indexed keywords

METHAMPHETAMINE;

ARTICLE; CHILD DEVELOPMENT; CHILD PARENT RELATION; FEMALE; HUMAN; LONGITUDINAL STUDY; PREGNANCY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SUBSTANCE ABUSE;

AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; CHILD DEVELOPMENT; FEMALE; HUMANS; INFANT; INFANT WELFARE; LONGITUDINAL STUDIES; MATERNAL BEHAVIOR; MENTAL HEALTH; METHAMPHETAMINE; PARENTING; POVERTY AREAS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; UNITED STATES;

EID: 34248531243     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990601175029     Document Type: Article

References (20)

1. "Greenblatt JC, Gfroerer JC. (1996). Methamphetamine abuse in the United States. Rockville, MD: U. S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies".
2. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000; 32(2):137-141.
3. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993; 329(12):850-854.
4. Derauf C, Katz AR, Frank DA, Grandinetti A, Easa D. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. J Drug Issues 2003; 3(4):1001-1016.
5. Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, Huestis M, Strauss A, Grotta SD, Liu J, Lester B. Methamphetamine and other substance use during pregnancy: Preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study. Matern Child Health J (Online First) 2006; Jan 5:1-10.
6. Hans SL. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol 1999; 26(1):55-74.
7. Nair P, Black MM, Schuler M, Keane V, Snow L, Rigney BA, Magder L. Risk factors for disruption in primary caregiving among infants of substance abusing women. Child Abuse Negl 1997; 21(11):1039-1051.
8. Arendt RE, Short EJ, Singer LT, Minnes S, Hewitt J, Flynn S, Carlson L, Min MO, Klein N, Flannery D. Children prenatally exposed to cocaine: Developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr 2004; 25(2):83-90.
9. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
10. Derogatis LR. Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual. 3rd ed. Minneapolis: National Computer Systems, Inc., 1993.
11. Miller FG, Roberts J, Brooks MK, Lazowski LE. Sassi-3 User's Guide. Bloomington, IN: Baugh Enterprises, Inc., 1997.
12. Blackwell TL, Toriello PL. Test review: substance abuse subtle screening inventory-3. Rehabilitation Counseling Bulletin 2005; 48(4):248-250.
13. Furstenberg FF, Hughes ME. Social capital and successful development. J Marriage and the Family 1995; 57:580-592.
14. Nair P, Schuler ME, Black MM, Kettinger L, Harrington D. Cumulative environmental risk in substance abusing women: Early intervention, parenting stress, child abuse potential, and child development. Child Abuse Negl 2003; 27(9):997-1017.
15. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Lu J, Finnegan LP, Maza PL. The maternal lifestyle study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110(6):1182-1192.
16. Conners NA, Bradley RH, Mansell LW, Liu JY, Roberts TJ, Burgdorf K, Herrell JM. Children of mothers with serious substance abuse problems: An accumulation of risks. Am J Drug Alcohol Abuse 2004; 30(1):85-100.
17. Joe KA. The lives and times of Asian-Pacific American drug users: An ethnographic study of their methamphetamine use. J Drug Issues 1996; 26(1):199-218.
18. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M. Methamphetamine treatment project. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13:181-190.
19. Semple SJ, Grant I, Patterson TL. Female methamphetamine users: Social characteristics and sexual risk behavior. Women & Health 2004; 40(3):35-50.
20. Bisagno V, Bowman R, Luine V. Functional aspects of estrogen neuroprotection. Endocrine 2003; 21(1):33-41.